Evidence map›Paper›PMID 34587155›Full record

ArticlePLoS genetics2021

Dynamic sumoylation of promoter-bound general transcription factors facilitates transcription by RNA polymerase II.

Mohammad S Baig, Yimo Dou, Benjamin G Bergey, Russell Bahar, Justin M Burgener, Marjan Moallem, James B McNeil, Akhi Akhter, Giovanni L Burke, Veroni S Sri Theivakadadcham and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Time-dependent changes in genome-wide gene expression and post-transcriptional regulation across the post-death process in silkworm.DNA research : an international journal for rapid publication of reports on genes and genomes · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Ubiquitin-like Proteins ofBiomolecules · 2023
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Mohammad S BaigDepartment of Biology, York University, Toronto, Ontario, Canada.ORCID 0000-0001-7455-2252
Yimo DouDepartment of Biology, York University, Toronto, Ontario, Canada.ORCID 0000-0002-7348-4179
Benjamin G BergeyDepartment of Biology, York University, Toronto, Ontario, Canada.
Russell BaharDepartment of Biology, York University, Toronto, Ontario, Canada.ORCID 0000-0003-4339-513X
Justin M BurgenerDepartment of Biology, York University, Toronto, Ontario, Canada.ORCID 0000-0001-9522-8865
Marjan MoallemDepartment of Biology, York University, Toronto, Ontario, Canada.
James B McNeilDepartment of Biology, York University, Toronto, Ontario, Canada.ORCID 0000-0002-7527-3295
Akhi AkhterDepartment of Biology, York University, Toronto, Ontario, Canada.
Giovanni L BurkeDepartment of Biology, York University, Toronto, Ontario, Canada.ORCID 0000-0002-2113-3406
Veroni S Sri TheivakadadchamDepartment of Biology, York University, Toronto, Ontario, Canada.ORCID 0000-0001-7663-4470
Patricia RichardStellate Therapeutics, New York, New York, United States of America.ORCID 0000-0002-9515-4509
Damien D'AmoursOttawa Institute of Systems Biology, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Emanuel RosoninaDepartment of Biology, York University, Toronto, Ontario, Canada.ORCID 0000-0001-6861-3143
York University · CAStella Therapeutics (United States) · USUniversity of Ottawa · CA

Funding

CIHR FDN-167265CIHR MOP-142282
6 · The paper itself

Abstract

Transcription-related proteins are frequently identified as targets of sumoylation, including multiple subunits of the RNA polymerase II (RNAPII) general transcription factors (GTFs). However, it is not known how sumoylation affects GTFs or whether they are sumoylated when they assemble at promoters to facilitate RNAPII recruitment and transcription initiation. To explore how sumoylation can regulate transcription genome-wide, we performed SUMO ChIP-seq in yeast and found, in agreement with others, that most chromatin-associated sumoylated proteins are detected at genes encoding tRNAs and ribosomal proteins (RPGs). However, we also detected 147 robust SUMO peaks at promoters of non-ribosomal protein-coding genes (non-RPGs), indicating that sumoylation also regulates this gene class. Importantly, SUMO peaks at non-RPGs align specifically with binding sites of GTFs, but not other promoter-associated proteins, indicating that it is GTFs specifically that are sumoylated there. Predominantly, non-RPGs with SUMO peaks are among the most highly transcribed, have high levels of TFIIF, and show reduced RNAPII levels when cellular sumoylation is impaired, linking sumoylation with elevated transcription. However, detection of promoter-associated SUMO by ChIP might be limited to sites with high levels of substrate GTFs, and promoter-associated sumoylation at non-RPGs may actually be far more widespread than we detected. Among GTFs, we found that TFIIF is a major target of sumoylation, specifically at lysines 60/61 of its Tfg1 subunit, and elevating Tfg1 sumoylation resulted in decreased interaction of TFIIF with RNAPII. Interestingly, both reducing promoter-associated sumoylation, in a sumoylation-deficient Tfg1-K60/61R mutant strain, and elevating promoter-associated SUMO levels, by constitutively tethering SUMO to Tfg1, resulted in reduced RNAPII occupancy at non-RPGs. This implies that dynamic GTF sumoylation at non-RPG promoters, not simply the presence or absence of SUMO, is important for maintaining elevated transcription. Together, our findings reveal a novel mechanism of regulating the basal transcription machinery through sumoylation of promoter-bound GTFs.

Indexed as

Promoter Regions, GeneticSumoylationTranscription, GeneticChromatinHumansLysineProtein BindingRNA Polymerase IISmall Ubiquitin-Related Modifier ProteinsTranscription Factors, GeneralChromatinLysineRNA Polymerase IISmall Ubiquitin-Related Modifier ProteinsTranscription Factors, General

Identifiers

PMID34587155
PMCPMC8505008
OpenAlexW3204862419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.